H. Yasuda, N. Shima, N. Nakagawa, and K. Yamaguchi, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proceedings of the National Academy of Sciences, vol.95, issue.7, pp.3597-3602, 1998.
DOI : 10.1073/pnas.95.7.3597

S. Teitelbaum, Bone Resorption by Osteoclasts, Science, vol.289, issue.5484, pp.1504-1508, 2000.
DOI : 10.1126/science.289.5484.1504

J. Li, I. Sarosi, and X. Yan, RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism, Proceedings of the National Academy of Sciences, vol.97, issue.4, pp.1566-1571, 2000.
DOI : 10.1073/pnas.97.4.1566

A. Naito, S. Azuma, and S. Tanaka, Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice, Genes to Cells, vol.7, issue.6, pp.353-362, 1999.
DOI : 10.1038/345442a0

G. Franzoso, L. Carlson, and L. Xing, Requirement for NF-kappaB in osteoclast and B-cell development, Genes Dev, vol.11, 1997.

L. Hofbauer, C. Dunstan, T. Spelsberg, B. Riggs, and S. Khosla, Osteoprotegerin Production by Human Osteoblast Lineage Cells Is Stimulated by Vitamin D, Bone Morphogenetic Protein-2, and Cytokines, Biochemical and Biophysical Research Communications, vol.250, issue.3, pp.776-7819394, 1998.
DOI : 10.1006/bbrc.1998.9394

T. Nakashima, Y. Kobayashi, S. Yamasaki, A. Kawakami, K. Eguchi et al., Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-??B Ligand: Modulation of the Expression by Osteotropic Factors and Cytokines, Biochemical and Biophysical Research Communications, vol.275, issue.3, pp.768-7753379, 2000.
DOI : 10.1006/bbrc.2000.3379

T. Crotti, M. Smith, H. Weedon, M. Ahern, D. Findlay et al., Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis, Annals of the Rheumatic Diseases, vol.61, issue.12, 2002.
DOI : 10.1136/ard.61.12.1047

E. Gravallese, C. Manning, A. Tsay, A. Naito, C. Pan et al., Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor, 2\250:AID- ANR3[3.0.CO, pp.250-258, 2000.
DOI : 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P

H. Ji, A. Pettit, and K. Ohmura, Critical Roles for Interleukin 1 and Tumor Necrosis Factor ?? in Antibody-induced Arthritis, The Journal of Experimental Medicine, vol.10, issue.1, pp.77-85, 2002.
DOI : 10.1016/S0140-6736(89)90430-3

J. Keffer, L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris et al., Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, EMBO J, vol.10, pp.4025-4031, 1991.

S. Kamijo, A. Nakajima, K. Ikeda, K. Aoki, K. Ohya et al., Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody, Biochemical and Biophysical Research Communications, vol.347, issue.1, pp.124-132, 2006.
DOI : 10.1016/j.bbrc.2006.06.098

P. Bekker, D. Holloway, and A. Rasmussen, A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women, Journal of Bone and Mineral Research, vol.273, issue.7, pp.1059-1066, 2004.
DOI : 10.1359/JBMR.040305

L. Santos, E. Morand, P. Hutchinson, N. Boyce, and S. Holdsworth, Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis, Clinical and Experimental Immunology, vol.107, issue.2, pp.248-253, 1997.
DOI : 10.1111/j.1365-2249.1997.263-ce1154.x

S. Chakrabarti and K. Patel, Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils, Journal of Leukocyte Biology, vol.78, issue.1, pp.279-288, 2005.
DOI : 10.1189/jlb.1004612

T. Felzmann, S. Gadd, O. Majdic, D. Maurer, P. Petera et al., Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis, Journal of Clinical Immunology, vol.247, issue.Suppl 97, pp.205-212, 1991.
DOI : 10.1007/BF00917426

L. Pronai, Y. Ichikawa, K. Ichimori, H. Nakazawa, and S. Arimori, Association of enhanced superoxide generation by neutrophils with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting anti-rheumatic drugs and disease activity, Clin Exp Rheumatol, vol.9, pp.149-155, 1991.

T. Kragstrup, K. Otkjaer, C. Holm, A. Jorgensen, M. Hokland et al., The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy, Cytokine, vol.41, issue.1, pp.16-23, 2008.
DOI : 10.1016/j.cyto.2007.10.004

F. Shen, M. Ruddy, P. Plamondon, and S. Gaffen, Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-??-induced genes in bone cells, Journal of Leukocyte Biology, vol.77, issue.3, pp.388-399, 2005.
DOI : 10.1189/jlb.0904490

P. Poubelle, A. Chakravarti, M. Fernandes, K. Doiron, and A. Marceau, Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils, Arthritis Research & Therapy, vol.9, issue.2, pp.10-1186, 2007.
DOI : 10.1186/ar2137

K. Pritzker, S. Gay, S. Jimenez, K. Ostergaard, J. Pelletier et al., Osteoarthritis cartilage histopathology: grading and staging, Osteoarthritis and Cartilage, vol.14, issue.1, pp.13-29, 2006.
DOI : 10.1016/j.joca.2005.07.014

W. Simonet, D. Lacey, and C. Dunstan, Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density, Cell, vol.89, issue.2, pp.309-319, 1997.
DOI : 10.1016/S0092-8674(00)80209-3

M. Daans, R. Lories, and F. Luyten, Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease, Arthritis Research & Therapy, vol.10, issue.5, pp.10-1186, 2008.
DOI : 10.1186/ar2518

T. Ikeda, M. Kasai, M. Utsuyama, and K. Hirokawa, Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus, Endocrinology, vol.142, pp.1419-1426, 2001.

I. Gonzalez-alvaro, A. Ortiz, E. Tomero, A. Balsa, J. Orte et al., Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists, Annals of the Rheumatic Diseases, vol.66, issue.12, pp.1675-1678, 2007.
DOI : 10.1136/ard.2007.071910

A. Pilichou, I. Papassotiriou, K. Michalakakou, S. Fessatou, E. Fandridis et al., High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-??B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis, Clinical Biochemistry, vol.41, issue.9, pp.746-749, 2008.
DOI : 10.1016/j.clinbiochem.2008.02.011

A. Toncheva, M. Remichkova, K. Ikonomova, P. Dimitrova, and N. Ivanovska, Inflammatory response in patients with active and inactive osteoarthritis, Rheumatology International, vol.119, issue.10, pp.1197-1203, 2009.
DOI : 10.1007/s00296-009-0864-0

URL : https://hal.archives-ouvertes.fr/pasteur-00709228